Pharmacogenomics & Personalized Medicine

Papers
(The H4-Index of Pharmacogenomics & Personalized Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy24
Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China21
The Relevance of Regenerating Gene 1a Polymorphisms to Radiation Sensitivity and Survival of Nasopharyngeal Carcinoma Receiving Radiotherapy in a Southern Chinese Population19
Genetic Variations of CARMN Modulate Glioma Susceptibility and Prognosis in a Chinese Han Population17
Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP16
The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review15
Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis15
Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population14
Clinical Characteristics and Gene Mutations of Two Families with MODY 3 in Inner Mongolia10
One Rare Warfarin Resistance Case and Possible Mechanism Exploration10
0.18044710159302